Securian Asset Management Inc. grew its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 1.2% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,323 shares of the company’s stock after acquiring an additional 118 shares during the quarter. Securian Asset Management Inc.’s holdings in Clorox were worth $1,634,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. AE Wealth Management LLC boosted its holdings in shares of Clorox by 5.3% in the fourth quarter. AE Wealth Management LLC now owns 15,148 shares of the company’s stock worth $2,126,000 after buying an additional 769 shares during the last quarter. Simmons Bank purchased a new position in shares of Clorox in the fourth quarter worth approximately $218,000. Moloney Securities Asset Management LLC boosted its holdings in shares of Clorox by 2.4% in the fourth quarter. Moloney Securities Asset Management LLC now owns 7,574 shares of the company’s stock worth $1,063,000 after buying an additional 178 shares during the last quarter. Armstrong Advisory Group Inc. purchased a new position in shares of Clorox in the fourth quarter worth approximately $80,000. Finally, Allworth Financial LP boosted its holdings in shares of Clorox by 2.2% in the first quarter. Allworth Financial LP now owns 3,812 shares of the company’s stock worth $603,000 after buying an additional 81 shares during the last quarter. Hedge funds and other institutional investors own 79.37% of the company’s stock.
Analyst Ratings Changes
CLX has been the topic of a number of recent analyst reports. Wells Fargo & Company raised their target price on shares of Clorox from $145.00 to $150.00 in a research note on Wednesday, May 3rd. Barclays raised their target price on shares of Clorox from $118.00 to $124.00 in a research note on Sunday, May 14th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Clorox from $147.00 to $149.00 in a research note on Tuesday, April 18th. Royal Bank of Canada raised their target price on shares of Clorox from $137.00 to $151.00 in a research note on Wednesday, May 3rd. Finally, Raymond James raised their target price on shares of Clorox from $165.00 to $185.00 in a research note on Wednesday, May 3rd. Seven research analysts have rated the stock with a sell rating, six have given a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $148.54.
Clorox Stock Performance
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $1.51 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.29. Clorox had a net margin of 1.03% and a return on equity of 114.67%. The company had revenue of $1.92 billion for the quarter, compared to analysts’ expectations of $1.82 billion. During the same quarter in the previous year, the business posted $1.31 earnings per share. Clorox’s quarterly revenue was up 5.9% on a year-over-year basis. On average, equities analysts predict that The Clorox Company will post 4.56 earnings per share for the current fiscal year.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- MarketBeat Week in Review – 7/10 – 7/14
- Wells Fargo’s Earnings, Why Markets Are Loving The Stock
- Citigroup Leads Banking Earnings, What’s Next?
- BlackRock Kicks Off Financials Earnings Season, Gauge To Markets
- JPMorgan Chase Is In Reversal But Don’t Chase It Higher
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
